`
`Novartis Pharma AG
`Postfach
`4022 Basel
`
`Confidential
`
`Bayer HealthCare AG
`Bayerwerk
`51368 Leverkusen
`Germany
`
`1 April 2014
`
`Confirmation of the scope of the Agreement(s) between Novartis and Vetter for Pre-filled Syringes
`
`(''Agreement") relating to the sublkense for the benefit of Bayer HealthCare .AG and its Affiliates
`
`Dear
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)01863785
`
`Novartis Exhibit 2146.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`•
`
`
`
`
`
`
`
`
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)01863785
`
`Novartis Exhibit 2146.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`•
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`The legal effects of this letter shall be determined by German law with the exclusion of the conflict
`
`of law rules and any rights and obligations generated by or arising from this letter shall be subject to
`
`German law.
`
`Yours sincerely
`
`NOVARTIS PHARMA AG
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)01863785
`
`Novartis Exhibit 2146.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)01863785
`
`Novartis Exhibit 2146.004
`Regeneron v. Novartis, IPR2021-00816
`
`